Published in J Clin Oncol on March 28, 2011
The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer (CQGOG0102) | NCT04409860
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol (2011) 2.85
Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys (2013) 1.19
Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol (2013) 1.08
Bringing the heavy: carbon ion therapy in the radiobiological and clinical context. Radiat Oncol (2014) 1.03
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecol Oncol (2013) 1.02
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. Br J Cancer (2013) 1.00
Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol (2012) 0.97
The role of PET/CT in cervical cancer. Front Oncol (2013) 0.93
The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future. Rep Pract Oncol Radiother (2013) 0.90
Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist (2013) 0.89
Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer (2013) 0.89
Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer. J Radiat Res (2012) 0.89
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation. Gynecol Oncol (2014) 0.88
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers (Basel) (2014) 0.87
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. J Transl Med (2012) 0.87
Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases. J Mol Med (Berl) (2012) 0.87
A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study. Gynecol Oncol (2011) 0.87
New molecular targets against cervical cancer. Int J Womens Health (2014) 0.85
Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer. Oncol Hematol Rev (2012) 0.83
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study. J Gynecol Oncol (2013) 0.83
Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma. Onco Targets Ther (2013) 0.82
Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB. World J Clin Oncol (2014) 0.82
Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. Front Oncol (2014) 0.81
Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys (2010) 0.81
Major clinical research advances in gynecologic cancer 2009. J Gynecol Oncol (2009) 0.81
Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies. Gynecol Obstet (Sunnyvale) (2011) 0.80
Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Radiat Oncol (2015) 0.80
Are we making progress in curing advanced cervical cancer? J Clin Oncol (2011) 0.78
SEOM guidelines for cervical cancer. Clin Transl Oncol (2015) 0.78
Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings. Drug Des Devel Ther (2016) 0.77
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy. Radiat Oncol (2016) 0.77
Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement. Am J Clin Oncol (2015) 0.77
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial. Eur J Nucl Med Mol Imaging (2016) 0.77
[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients. Radiother Oncol (2015) 0.77
From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer. BMC Cancer (2015) 0.76
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol (2017) 0.75
Conventional external beam volumes for cervical cancer: Are they adequate? South Asian J Cancer (2013) 0.75
A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer. Cancer Biol Ther (2015) 0.75
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond. Am Soc Clin Oncol Educ Book (2015) 0.75
Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation. Am J Clin Oncol (2016) 0.75
Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients. Radiat Oncol (2015) 0.75
[Glassy cell carcinoma of the cervix: report of a case and literature review]. Pan Afr Med J (2015) 0.75
Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis. Medicine (Baltimore) (2017) 0.75
Novel agents and treatment techniques to enhance radiotherapeutic outcomes in carcinoma of the uterine cervix. Ann Transl Med (2016) 0.75
Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB-IVA cervical cancer. Gynecol Oncol Rep (2014) 0.75
Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients. J Gynecol Oncol (2017) 0.75
The role of cisplatin alternative regimens with radiotherapy in cervical cancer. Gynecol Oncol Rep (2014) 0.75
Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents. Obstet Gynecol Int (2013) 0.75
Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision. J Gynecol Oncol (2014) 0.75
Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups. Chin J Cancer Res (2016) 0.75
High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer. J Gynecol Oncol (2015) 0.75
Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? J Cancer Res Clin Oncol (2017) 0.75
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol (2010) 13.03
In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives. Acta Pharm (2008) 2.76
ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci (2005) 2.24
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol (2008) 2.10
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer. J Clin Oncol (2007) 2.06
Syntheses, urease inhibition, and antimicrobial studies of some chiral 3-substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles. Med Chem (2008) 1.88
6-(1-Adamant-yl)-3-(2-fluoro-phen-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole. Acta Crystallogr Sect E Struct Rep Online (2009) 1.47
4-Chloro-benzothio-amide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.43
Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A (2012) 1.38
Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes. Nat Neurosci (2010) 1.36
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial. World J Gastroenterol (2010) 1.36
A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis. J Biol Chem (2011) 1.33
Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiat Oncol (2011) 1.28
Chemistry of isocoumarins: synthesis and biological screenings of homalicine and dihydrohomalicine. Nat Prod Res (2005) 1.24
Osteoprotegerin in prostate cancer bone metastasis. Cancer Res (2005) 1.24
5-(4-Fluoro-phen-yl)-5-methyl-imidazolidine-2,4-dione. Acta Crystallogr Sect E Struct Rep Online (2008) 1.23
[4-(Methoxy-carbon-yl)benz-yl]triphenyl-phospho-nium bromide hemihydrate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.21
4-Bromo-thio-benzamide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.20
Characterization of the G alpha(s) regulator cysteine string protein. J Biol Chem (2005) 1.17
Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells. Proc Natl Acad Sci U S A (2012) 1.17
A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer. J Thorac Oncol (2011) 1.16
D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry. Neuron (2008) 1.12
Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol (2007) 1.10
Evolutionary relationships and protein domain architecture in an expanded calpain superfamily in kinetoplastid parasites. J Mol Evol (2005) 1.10
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer. Eur J Cancer (2013) 1.09
Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid. J Enzyme Inhib Med Chem (2010) 1.08
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer. Lung Cancer (2012) 1.05
(E)-4-(4-Fluoro-styr-yl)benzoic acid. Acta Crystallogr Sect E Struct Rep Online (2008) 1.04
1-(4-Chloro-phenyl-sulfon-yl)-5-(4-fluoro-phen-yl)-5-methyl-imidazolidine-2,4-dione. Acta Crystallogr Sect E Struct Rep Online (2009) 1.00
3-Methyl-thio-benzamide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.99
Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels. Mol Cell Neurosci (2005) 0.97
Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res (2007) 0.97
(2S)-Methyl 2-(p-toluenesulfonamido)propanoate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.96
Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem (2009) 0.95
2-(4-Bromo-phen-oxy)propanohydrazide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.95
Adamantane-1-thio-amide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.92
Regulation of the KV4.2 complex by CaV3.1 calcium channels. Channels (Austin) (2011) 0.92
Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur J Med Chem (2010) 0.92
Echocardiographic profile of rheumatic heart disease at a tertiary cardiac centre. J Ayub Med Coll Abbottabad (2010) 0.92
Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from α-amino acids. J Enzyme Inhib Med Chem (2011) 0.91
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. Gynecol Oncol (2011) 0.91
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Gen Physiol (2008) 0.91
l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2007) 0.90
Biostatistics primer: what a clinician ought to know--prognostic and predictive factors. J Thorac Oncol (2013) 0.89
Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review. Clin Lung Cancer (2011) 0.88
1-(4-Methoxy-phenyl-sulfon-yl)-5-methyl-5-phenyl-imidazolidine-2,4-dione. Acta Crystallogr Sect E Struct Rep Online (2009) 0.87
4-(4-Propoxybenzo-yloxy)benzoic acid. Acta Crystallogr Sect E Struct Rep Online (2008) 0.87
Molecular determinants of Rem2 regulation of N-type calcium channels. Biochem Biophys Res Commun (2008) 0.87
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. Clin Breast Cancer (2011) 0.86
(S)-N-{1-[5-(4-Chloro-benzyl-sulfanyl)-1,3,4-oxadiazol-2-yl]eth-yl}-4-methyl-benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online (2011) 0.86
4-n-Butyl-3-(3-methyl-phen-yl)-1H-1,2,4-triazol-5(4H)-one. Acta Crystallogr Sect E Struct Rep Online (2008) 0.85
Low sensitivity of histology to predict the presence of microorganisms in suspected aseptic loosening of a joint prosthesis. Mod Pathol (2006) 0.85
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. J Thorac Oncol (2010) 0.85
IKCa channels are a critical determinant of the slow AHP in CA1 pyramidal neurons. Cell Rep (2015) 0.85
[Comparative parameters of myelotoxicity in patients treated with simultaneous chemotherapy and radiotherapy or only radiotherapy]. Med Arh (2004) 0.84
The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. PLoS One (2012) 0.84
A systematic review of the interobserver variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer. J Thorac Oncol (2011) 0.83
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer. Clin Breast Cancer (2008) 0.83
4-Methoxy-benzene-carbothio-amide. Acta Crystallogr Sect E Struct Rep Online (2010) 0.83
The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer. Bosn J Basic Med Sci (2004) 0.82
(R)-1-(4-Bromo-benzo-yl)-4-(1-phenyl-prop-yl)thio-semicarbazide. Acta Crystallogr Sect E Struct Rep Online (2008) 0.82
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy. Clin Breast Cancer (2010) 0.82
Primary gliosarcoma--clinical experience from a regional cancer centre in north India. Br J Neurosurg (2011) 0.81
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer. Clin Cancer Res (2008) 0.81
Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system. Pflugers Arch (2014) 0.80
Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries. Int J Radiat Oncol Biol Phys (2007) 0.80
Evidence of recombination in the Banana bunchy top virus genome. Infect Genet Evol (2011) 0.79
Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: a retrospective comparison of East Asian and global studies. Asia Pac J Clin Oncol (2013) 0.78
Synthesis, crystal structure and anti-HIV activity of 2-adamantyl/adamantylmethyl-5-aryl-1,3,4-oxadiazoles. Med Chem (2012) 0.78
Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. Respirology (2011) 0.77
Highly enantioselective Michael addition of 2-oxindoles to vinyl selenone in RTILs catalyzed by a Cinchona alkaloid-based thiourea. Chem Commun (Camb) (2011) 0.77
Advanced imaging applications for locally advanced cervical cancer. Asian Pac J Cancer Prev (2012) 0.77
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer. Lung Cancer (2007) 0.77
A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up. Breast Cancer (2012) 0.77
Investigation of IVS14 + 1G > A polymorphism of DPYD gene in a group of Bosnian patients treated with 5-Fluorouracil and capecitabine. Bosn J Basic Med Sci (2010) 0.77
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I study. Gynecol Oncol (2009) 0.77
Hyperthermia in combination with radiation therapy for treatment of advanced inoperable breast cancer. J Med Assoc Thai (2003) 0.76
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer. Clin Breast Cancer (2012) 0.76
Concurrent radiation therapy and irinotecan in stage IIIB cervical cancer. J Med Assoc Thai (2003) 0.76
4-(4-Octyloxybenzo-yloxy)benzoic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 0.76
Uterine sarcoma-current management and experience from a regional cancer centre in North India. Arch Gynecol Obstet (2013) 0.76
3-(4-Bromo-phenyl-sulfon-yl)-8-methyl-1,3-diaza-spiro-[4.5]decane-2,4-dione. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
4-Methyl-benzene-carbothio-amide. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Comprehensive review of chemotherapy in patients with metastatic breast cancer. J Clin Oncol (2005) 0.75
1-(4-Ethoxy-benzo-yl)-4-(4-methoxy-phen-yl)thiosemicarbazide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
3-(4-Chloro-phenyl-sulfon-yl)-8-methyl-1,3-diaza-spiro-[4.5]decane-2,4-dione. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
4-Eth-oxy-benzohydrazide. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
4,4,6a,6b,11,12,14b-Heptamethyl-16-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,9,10,11,12,12a,14a,14b-octa-deca-hydro-12b,8a-(epoxy-methano)-picen-3-yl acetate. Acta Crystallogr Sect E Struct Rep Online (2013) 0.75
6-(Adamantan-1-yl)-3-(3-fluoro-phen-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
5-[1-(3,4-Dichloro-phen-oxy)eth-yl]-1,3,4-oxadiazole-2(3H)-thione hemihydrate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(S)-N-[1-(5-Benzyl-sulfan-yl-1,3,4-oxa-diazol-2-yl)-2-phenyl-eth-yl]-4-methyl-benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
(2S)-Methyl 2-(4-chloro-benzene-sulfon-amido)-4-(methyl-sulfan-yl)butanoate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
2-(2-Fluoro-biphenyl-4-yl)-N'-(propan-2-yl-idene)propanohydrazide. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75